Getting on Wegovy requires meeting specific weight-based criteria and obtaining a prescription from a licensed healthcare provider. The process involves a medical evaluation, a prescription, navigating insurance coverage or paying out of pocket, and then a gradual 16-week dose increase before reaching the full treatment dose. Here’s what each step looks like in practice.
Who Qualifies for Wegovy
The FDA approved Wegovy for adults who have a BMI of 30 or higher (classified as obesity) or a BMI of 27 to 29.9 (overweight) with at least one weight-related health condition. Those conditions include type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea. Adolescents aged 12 and older qualify if their BMI falls at or above the 95th percentile for their age and sex.
Wegovy also carries a separate FDA approval for reducing the risk of heart attack, stroke, and cardiovascular death in adults with established heart disease who are obese or overweight. If you fall into that category, your doctor may bring up Wegovy even if weight loss isn’t your primary goal.
There are a few groups who cannot take Wegovy at all. It’s contraindicated for anyone with a personal or family history of medullary thyroid cancer or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It’s also off-limits if you’ve ever had a serious allergic reaction to semaglutide, the active ingredient.
Getting a Prescription: In-Person or Telehealth
You can get a Wegovy prescription through your primary care doctor, an endocrinologist, an obesity medicine specialist, or a telehealth platform. At your visit, the provider will record your current BMI, review any weight-related conditions you have, and ask about previous weight loss efforts. Most providers want to see that you’ve already tried diet and exercise changes, though this isn’t a formal FDA requirement.
Telehealth is a fully legal route for Wegovy in many states. Because semaglutide is not a controlled substance, the federal rules that require in-person visits for certain prescriptions don’t apply. States like California, Connecticut, Illinois, New York, Pennsylvania, and Washington allow complete telehealth evaluations with no in-person visit required. However, some states have stricter rules. Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, Texas, and Utah typically expect an initial face-to-face exam. Florida requires a follow-up visit at least every three months, and Virginia requires a check-in about 30 days after starting treatment.
When choosing a telehealth provider, make sure the prescribing clinician holds an active medical license in the state where you’re physically located. Physicians (MDs and DOs) can prescribe via telehealth in all states. Nurse practitioners can prescribe independently in some states (California, Washington, New York, Arizona, Utah) and under physician oversight in others (Texas, Florida, Georgia, Pennsylvania).
Dealing With Insurance and Prior Authorization
Insurance coverage for Wegovy varies widely, and most plans that do cover it require prior authorization. This means your doctor’s office submits paperwork proving you meet the plan’s criteria before the pharmacy can fill the prescription. The insurer will typically ask for your recent BMI (often documented within the last 90 days), a list of relevant health conditions, evidence of previous weight loss attempts, and a treatment plan that includes lifestyle changes alongside the medication.
Some insurance plans are more restrictive than others. Maryland’s Medicaid program, for example, currently limits coverage to patients with established cardiovascular disease who are also obese or overweight, and explicitly excludes patients with diabetes. Your plan’s criteria may differ, so it’s worth calling your insurer or checking their formulary before your appointment. Many employer-sponsored plans and Medicare Part D plans still exclude weight loss medications entirely.
If your insurance does cover Wegovy, the manufacturer offers a savings card that can bring your copay down to as little as $25 per month. This card is available to commercially insured patients and can make a significant difference, since the retail price of Wegovy without any coverage is around $1,349 per month.
What to Expect if You’re Paying Out of Pocket
Without insurance, you’re looking at roughly $1,349 per month at retail. Some patients use manufacturer coupons, pharmacy discount programs, or negotiate with specialty pharmacies to reduce that cost. The manufacturer’s savings program is designed for insured patients, so it generally won’t apply if you’re completely uninsured. Some telehealth platforms negotiate bulk pricing or offer subscription models that bundle the medication cost with visits, but it’s important to confirm you’re receiving brand-name Wegovy and not a compounded version, which is a different product with different regulatory oversight.
How the Dose Ramps Up
Wegovy isn’t prescribed at full strength from day one. You follow a 16-week escalation schedule designed to let your body adjust and reduce nausea and other digestive side effects. The schedule works like this:
- Weeks 1 through 4: 0.25 mg once weekly
- Weeks 5 through 8: 0.5 mg once weekly
- Weeks 9 through 12: 1 mg once weekly
- Weeks 13 through 16: 1.7 mg once weekly
- Week 17 onward: 2.4 mg once weekly (maintenance dose)
Each dose comes as a prefilled pen that you inject under the skin of your abdomen, thigh, or upper arm. You pick one day per week and stick with it. The injection itself takes a few seconds. For adults, the recommended maintenance dose is 2.4 mg, though some people stay at 1.7 mg if they can’t tolerate the higher dose. Adolescents are started on the same escalation but are expected to reach the full 2.4 mg.
Because each dose level requires a different pen, you’ll fill a new prescription (or a new pen strength) roughly every four weeks during the escalation phase. This is worth knowing because each step may trigger a new prior authorization or pharmacy order.
What Wegovy Does and How Well It Works
Wegovy mimics a hormone your gut naturally releases after eating. It slows stomach emptying, reduces appetite, and changes how your brain processes hunger and fullness signals. The net effect is that you eat less without the constant feeling of fighting cravings.
In the pivotal clinical trial (known as STEP 1), participants used Wegovy for 68 weeks, roughly a year and a half, alongside reduced-calorie eating and increased physical activity. The trial demonstrated clinically meaningful weight loss compared to placebo, and it was this data that supported FDA approval. Beyond weight, a large cardiovascular outcomes trial found that Wegovy reduced the rate of heart attack, stroke, and cardiovascular death from 8% in the placebo group to 6.5% in the treatment group.
Wegovy is intended as a long-term medication. Weight regain after stopping is common and well-documented, so most providers frame it as an ongoing treatment rather than a short course.
A Quick Summary of Steps
- Check your BMI: You need a BMI of 30 or higher, or 27 or higher with a weight-related health condition.
- Schedule a visit: See your doctor or use a legitimate telehealth platform licensed in your state.
- Prepare for prior authorization: Your provider will submit documentation to your insurer. Have recent weight records and a history of previous weight loss efforts ready.
- Check costs: Ask about the manufacturer savings card if you have commercial insurance. If uninsured, compare pharmacy pricing before filling.
- Start low: Begin at 0.25 mg weekly and expect to reach the full dose around week 17.
- Plan for the long term: Wegovy works best as an ongoing treatment paired with dietary changes and physical activity.